Global Cephalosporin Market to Reach US$ 24.4 Billion by 2032, Catalyzed by Increasing Prevalence of Infectious Diseases

December 09, 2021 | Healthcare

According to the latest report by IMARC Group, titled “Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2024-2032”, the global cephalosporin market size reached US$ 19.3 Billion in 2023. Cephalosporins refer to antibiotics that are utilized to treat a wide array of bacterial infections. They belong to a class known as beta-lactams, which work in a similar way to penicillin. Depending upon the type of infection, the route of administration of these antibiotics varies from oral to intravenous use. There are five generations of cephalosporins available which are distinguished on the basis of their antibacterial spectrum. These drugs are extensively utilized by healthcare professionals for the treatment of gonorrhea, meningitis, sinusitis, urinary tract infection, skin infections, pelvic inflammatory disease, kidney infections, bone infections and epididymo-orchitis, owing to their safe nature, enhanced efficacy and low toxicity.

Global Cephalosporin Market Trends:

The global market is primarily driven by an increase in the incidences of infectious diseases. Apart from this, the rise in air and water pollution levels has resulted in the increasing prevalence of respiratory diseases. Consequently, the demand for antibiotics is bolstering, which in turn is creating a positive outlook for the market. Moreover, significant investments in research and development (R&D) in the field of antibiotics is expected to provide a stimulus to the market growth. Furthermore, technological advancements and several breakthroughs in the medical industry are also contributing to the market growth. For instance, improvements in genetic engineering have enabled the development of an effective pathway toward the 7-amino-desacetoxycephalosporanic acid (7-ADCA) structure within the producing organism. Since semisynthetic cephalosporins are made from 7-ADCA, the discovery of this bioprocess is anticipated to create a positive outlook for the market. On account of the aforementioned factors, the market is expected to reach a value of US$ 24.4 Billion by 2032, expanding at a CAGR of 2.6% during 2024-2032.

Market Summary:

  • On the basis of the generation, the market has been divided into first, second, third, fourth and fifth generations.
  • Based on the route of administration, the market has been bifurcated into injection and oral.
  • On the basis of the application, the market has been categorized into respiratory tract, skin infection, ear infection, urinary tract infection, sexually transmitted infection and others.
  • On the geographical front, the market has been segregated into Asia Pacific, Europe, North America, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has been studied in the report, along with the detailed profiles of the key players. Some of the players operating in the market include Allergan, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co., Inc., Novartis International AG (Sandoz), Pfizer Inc., Groupe Sanofi, Teva Pharmaceutical Industries Ltd., Abbott Laboratories, and Sun Pharmaceutical Industries Limited.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cephalosporin Market to Reach US$ 24.4 Billion by 2032, Catalyzed by Increasing Prevalence of Infectious Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More